Disclosures: Dilara Turan Gokce: Nothing to Disclose, Derya Ari: Nothing to Disclose, Ilkay Idilman: Nothing to Disclose, Meral Akdogan: Nothing to Disclose 2055 DELETION OF ETS1 IN HEPATIC STELLATE CELLS ACCELERATES DEVELOPMENT OF LIVER FIBROSIS Wonseok Lee 1 Xiao Liu 1 Hyun Young Kim 1 Karin Diggle 1 David Brenner 2 Tatiana Kisseleva 1 , 1 University of California, San Diego, 2 Sanford Burnham Prebys Medical Discovery Institute Background: In response to chronic liver injury, quiescent Hepatic Stellate Cells (HSCs) activate into Collagen Type-I-producing myofibroblasts (activated HSCs), leading to the development of hepatic fibrosis
Enriched with Alpha Arbutin and Glutathione for intense skin lightening
(2009) 296:L1567
A small number of double-blind, placebo-controlled clinical trials, with a degree of variability in enrollment criteria, intervention, and outcome measures, have been conducted to test whether additional antibiotics are effective (80, 83, 135, 154, 155)